PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
1618948-1	1992	Thimerosal causes synthesis and/or release of both endothelium-derived relaxing factor (EDRF) and prostaglandins from conductance vessels in vitro.	Thimerosal	0-10	alpha hemoglobin stabilizing protein	Mus musculus	51-86	
1618948-1	1992	Thimerosal causes synthesis and/or release of both endothelium-derived relaxing factor (EDRF) and prostaglandins from conductance vessels in vitro.	Thimerosal	0-10	alpha hemoglobin stabilizing protein	Mus musculus	88-92	
1618948-8	1992	The ability of thimerosal to dilate arterioles was eliminated not only by treatments thought to eliminate synthesis/release of EDRF, but also by cyclooxygenase inhibitors.	Thimerosal	15-25	alpha hemoglobin stabilizing protein	Mus musculus	127-131	
1618948-11	1992	We conclude that the dilating effects of thimerosal on diameter require two endothelium-derived agents: EDRF and one or more prostaglandins acting in concert.	Thimerosal	41-51	alpha hemoglobin stabilizing protein	Mus musculus	104-108	
1618948-12	1992	However, the inhibiting effect of thimerosal on local platelet adhesion/aggregation appears to be caused only by an increase in EDRF at the injured site.	Thimerosal	34-44	alpha hemoglobin stabilizing protein	Mus musculus	128-132